Home > Pharma

Neowater, a Revolutionary Solution for Drug Development

The pharma industry is facing a major challenge during the discovery and development stages. Hundreds, if not thousands, of compounds with proven activity have been stranded within development because of formulation problems. This becomes even more critical, given that there are few new APIs, forcing scientists to find different techniques to overcome the formulation barriers that not only pose health risks, but also affect profitability. The problem is how to formulate a hydrophobic API with as few additives and as minimal toxicity as possible without hindering the biological activity. Neowater offers the potential to release these compounds back into the drug development chain. It is a natural, safe (DMF# 20503), cost-effective delivery agent that can be deployed throughout the development cycle – from initial compound formulation to human ingestion. Neowater, which closely resembles naturally occurring water in biological organisms, assists in overcoming the barriers of reintroducing hydrophobic and hydrophilic compounds into living systems. Do-Coop has successfully formulated numerous compounds with Neowater, dramatically reducing the levels of toxic agents while maintaining or enhancing compound efficacy.   Click on the following link to view additional pharmaceutical applications for Neowater [Pharma Applications]